Horizon / Plein textes La base de ressources documentaires de l'IRD

IRD

 

Publications des scientifiques de l'IRD

Aron-Wisnewsky J., Prifti E., Belda E., Ichou F., Kayser B. D., Dao M. C., Verger Eric, Hedjazi L., Bouillot J. L., Chevallier J. M., Pons N., Le Chatelier E., Levenez F., Ehrlich S. D., Dore J., Zucker Jean-Daniel, Clement K. (2019). Major microbiota dysbiosis in severe obesity : fate after bariatric surgery. Gut, 68 (1), 70-82. ISSN 0017-5749

Accès réservé (Intranet IRD) Demander le PDF

Lien direct chez l'éditeur doi:10.1136/gutjnl-2018-316103

Titre
Major microbiota dysbiosis in severe obesity : fate after bariatric surgery
Année de publication2019
Type de documentArticle référencé dans le Web of Science WOS:000455727900013
AuteursAron-Wisnewsky J., Prifti E., Belda E., Ichou F., Kayser B. D., Dao M. C., Verger Eric, Hedjazi L., Bouillot J. L., Chevallier J. M., Pons N., Le Chatelier E., Levenez F., Ehrlich S. D., Dore J., Zucker Jean-Daniel, Clement K.
SourceGut, 2019, 68 (1), p. 70-82. ISSN 0017-5749
RésuméObjectives Decreased gut microbial gene richness (MGR) and compositional changes are associated with adverse metabolism in overweight or moderate obesity, but lack characterisation in severe obesity. Bariatric surgery (BS) improves metabolism and inflammation in severe obesity and is associated with gut microbiota modifications. Here, we characterised severe obesity-associated dysbiosis (ie, MGR, microbiota composition and functional characteristics) and assessed whether BS would rescue these changes. Design Sixty-one severely obese subjects, candidates for adjustable gastric banding (AG B, n=20) or Roux-en-Ygastric bypass (RYGB, n=41), were enrolled. Twenty-four subjects were followed at 1, 3 and 12 months post-BS. Gut microbiota and serum metabolome were analysed using shotgun metagenomics and liquid chromatography mass spectrometry (LC-MS). Confirmation groups were included. Results L ow gene richness (LGC) was present in 75% of patients and correlated with increased trunk-fat mass and comorbidities (type 2 diabetes, hypertension and severity). Seventy-eight metagenomic species were altered with LGC, among which 50% were associated with adverse body composition and metabolic phenotypes. Nine serum metabolites (including glutarate, 3-methoxyphenylacetic acid and L-histidine) and functional modules containing protein families involved in their metabolism were strongly associated with low MGR. BS increased MGR 1 year postsurgery, but most RYGB patients remained with low MGR 1 year postBS, despite greater metabolic improvement than AG B patients. Conclusions We identified major gut microbiota alterations in severe obesity, which include decreased MGR and related functional pathways linked with metabolic deteriorations. The lack of full rescue postBS calls for additional strategies to improve the gut microbiota ecosystem and microbiome-host interactions in severe obesity.
Plan de classementNutrition, alimentation [054] ; Biotechnologies [084]
Descr. géo.FRANCE
LocalisationFonds IRD [F B010074930]
Identifiant IRDfdi:010074930
Lien permanenthttp://www.documentation.ird.fr/hor/fdi:010074930

Export des données

Disponibilité des documents

Télechargment fichier PDF téléchargeable

Lien sur le Web lien chez l'éditeur

Accès réservé en accès réservé

HAL en libre accès sur HAL


Accès aux documents originaux :

Le FDI est labellisé CollEx

Accès direct

Bureau du chercheur

Site de la documentation

Espace intranet IST (accès réservé)

Suivi des publications IRD (accès réservé)

Mentions légales

Services Horizon

Poser une question

Consulter l'aide en ligne

Déposer une publication (accès réservé)

S'abonner au flux RSS

Voir les tableaux chronologiques et thématiques

Centres de documentation

Bondy

Montpellier (centre IRD)

Montpellier (MSE)

Cayenne

Nouméa

Papeete

Abidjan

Dakar

Niamey

Ouagadougou

Tunis

La Paz

Quito